Release of financial calendar for 2025

Investor News
14 November 2024

Release of financial calendar for 2025 

04 February		Deadline for receipt of resolutions for the Annual General Meeting
21 February		2024 Annual Report
19 March		Annual General Meeting
09 May		Interim Report, Q1 2025
15 August		Interim Report, Q2 2025
19 November		Interim Report, Q3 2025

Contact

Investors
Jacob Johansen, Head of Investor Relations
+45 2169 3591 / [email protected]

Press        
Louise Westh Naldal, Head of Group Communications
+45 2982 0022 / [email protected]

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
• Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
• HII Christens Virginia-Class Attack Submarine Arkansas (SSN 800)